This can be sustained as a memory T cell response in combination with anti-CD40 repolarisation in a syngeneic pancreatic cancer mouse model, for which anti-CD40 monotherapy is insufficient [117]. This evidence concerns the gene CD40 and pancreatic neoplasm.